Follow
Robert Flatman
Robert Flatman
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Longitudinal study of bone turnover after acute spinal cord injury
D Roberts, W Lee, RC Cuneo, J Wittmann, G Ward, R Flatman, ...
The Journal of Clinical Endocrinology & Metabolism 83 (2), 415-422, 1998
2651998
Limited clinical utility of high-sensitivity plasma C-reactive protein assays
B Campbell, T Badrick, R Flatman, D Kanowski
Annals of clinical biochemistry 39 (2), 85-88, 2002
872002
Consensus statement for the management and communication of high risk laboratory results
C Campbell, G Caldwell, P Coates, R Flatman, A Georgiou, AR Horvath, ...
The Clinical Biochemist Reviews 36 (3), 97, 2015
242015
Problems with high-sensitivity C-reactive protein
B Campbell, R Flatman, T Badrick, D Kanowski
Clinical Chemistry 49 (1), 201-202, 2003
192003
Roche IFCC methods for lactate dehydrogenase tested for duplicate errors with Greiner and Becton-Dickinson lithium-heparin and Greiner serum samples
G Dimeski, T Badrick, R Flatman, B Ormiston
Clinical chemistry 50 (12), 2391-2392, 2004
182004
Terminology, units and reporting–how harmonized do we need to be?
R Flatman
Clinical Chemistry and Laboratory Medicine (CCLM) 57 (1), 1-11, 2018
152018
An update report on the harmonization of adult reference intervals in Australasia
G Koerbin, K Sikaris, GRD Jones, R Flatman, JR Tate, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 57 (1), 38-41, 2018
142018
Oral glucose tolerance test to diagnose gestational diabetes mellitus: impact of variations in specimen handling
EL Jamieson, G Dimeski, R Flatman, PE Hickman, GRD Jones, JV Marley, ...
Clinical Biochemistry 115, 33-48, 2023
82023
Understanding the ‘Silver Book’—An important reference for standardised nomenclature in clinical laboratory sciences
R Flatman, G Férard, R Dybkaer
Clinica Chimica Acta 467, 4-7, 2017
82017
Calculated chemistry parameters–do they need to be harmonised?
D Hughes, JCG Doery, KW Choy, R Flatman
The Clinical Biochemist Reviews 37 (3), 131, 2016
82016
Indirect derivation of biological variation data and analytical performance specifications for therapeutic drug monitoring activities
JH Chai, R Flatman, B Teis, SK Sethi, T Badrick, TP Loh
Pathology 51 (3), 281-285, 2019
72019
Recommendations for reporting and flagging of reference limits on pathology reports
R Flatman, M Legg, GRD Jones, P Graham, D Moore, J Tate
The Clinical Biochemist Reviews 35 (4), 199, 2014
52014
Deriving Sonic network reference intervals for children
KA Sikaris, Z Lu, D Kanowski, L Price, R Flatman, G Caldwell, N Taylor, ...
Clin Biochem Rev 30 (Suppl), S20, 2009
52009
The inappropriate use of statistics
TC Badrick, RJ Flatman
New Zealand Journal of Medical Laboratory Science 53 (3), 95-103, 1999
41999
Coding for pathology tests–strengths and weaknesses
R Flatman
The Clinical Biochemist Reviews 33 (3), 109, 2012
12012
Properties and units in the clinical laboratory sciences. Part XXVII: online dynamic NPU manual (IUPAC Technical Report)
YB Lee Hansen, K Toska, A Lund, R Flatman, R Ceder
Pure and Applied Chemistry 95 (2), 125-131, 2023
2023
Recommended ‘starter’alert thresholds for a selection of chemical pathology tests
C Campbell, G Caldwell, P Coates, R Flatman, A McNeil, H Schneider, ...
Pathology 55, S83, 2023
2023
A simple, fast, high-throughput, modified method for the simultaneous determination of citrate and oxalate in a single purified urine sample using two commercially available kits
G Pool, M Dobson, M Baxter, R Flatman, G Ward, G Daley, C Bachmeier, ...
Pathology 55, S84, 2023
2023
Quality specimen project
CJ Ison, A Jennings, GM Daley, GJ Ward, R Flatman, LA Price
Pathology 54, S64, 2022
2022
Reply to Dr Hawkins regarding comparability of results for monitoring
K Sikaris, G Koerbin, G Jones, R Flatman
Clinical Chemistry and Laboratory Medicine (CCLM) 59 (5), e221-e222, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20